a revolutionary auto-injector

Problem

Anaphylaxis is a severe allergic reaction when a patient is exposed to an antigen to which they have become hyperallergic. Exposure to these antigens results in the release of mediators from mast cells in the body, causing inflammation of critical organ systems. 

This leads to abdominal cramping, heart palpitations, vomiting, swelling of the face, and breathing problems. Without immediate treatment, it can lead to patient mortality within 15 minutes.

To increase the probability of patient survival, a dose of adrenaline must be administered. There are several routes of administration, but the use of an Adrenaline Auto-Injector is the safest, quickest and most efficient route. 

The continuous annual purchase of an adrenaline auto-injector due to expiration and non-use is a major issue for patients across the globe. Furthermore, current devices do not effectively cater to variation in patient weight and body type.

Breakthrough

Adrenaline auto-injectors treat life-threatening severe allergic reactions – buying precious time to get to the hospital. 

ZiBiPen delivers its dose in the form of a reloadable cartridge at a fraction of the cost of the dominant device on the market.

Estimated Time of Arrival

2022 – The ZiBiPen is in the second phase of development to make sure the device is both effective and safe for use by all ages and body types.